IGF1R and carcinoma: miR-145 (median 2.2 (from 0.01 to 12.6)) had variable expression in the adrenocortical tumors that were evaluated; however, these values were not correlated with the expression values of IGF1R in adrenocortical adenomas and carcinomas.